key: cord-0780343-k0nw0yf1 authors: Oli, Angus Nnamdi; Edeh, Peter Anyigor; Al-Mosawi, Reham M.; Amara Mbachu, Nancy; Al-Dahmoshi, Hussein O.M.; Al-Khafaji, Noor S.K.; Onyeukwu Ekuma, Uchechukwu; Moses Okezie, Ugochukwu; Saki, Morteza title: Evaluation of the phytoconstituents of Auricularia auricula-judae mushroom and antimicrobial activity of its protein extract date: 2020-07-29 journal: Eur J Integr Med DOI: 10.1016/j.eujim.2020.101176 sha: 715e0e9378ad4bb9ec2643aca2611922189fd99a doc_id: 780343 cord_uid: k0nw0yf1 INTRODUCTION: The growing resistance to antibiotics and the complexity of defeating multi-drug resistant bacteria have led to an increase in the search for novel and effective antimicrobials from various plants. This study aimed to determine the bioactive contents of Auricularia auricular-judae mushroom and evaluate the antimicrobial potential of its protein extract against some selected human bacterial and fungal pathogens which could serve as a lead to the discovery of new antimicrobial agents. METHODS: The constituents of the A. auricular-judae were evaluated by standard phytochemical analysis methods. The agar well diffusion, micro-broth dilution, and time-kill kinetic assays were used to determine the antimicrobial activity of the extracts against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, yeast (Candida albicans), and dermatophytic pathogens. RESULTS: The preliminary phytochemical analysis of the extracts revealed the presence of carbohydrate (43.15%; 38.30%) proteins (23.75%; 23.75%), flavonoids (1.20%; 0.80%), alkaloids (0.60%; 1.00%), Saponin (6.00%; 2.40% ), Tannin (1.65%; 1.57%), Cyanide (0.24%; 0.40%), Ash (12.40%; 10.40%), moisture (6.00%;6.00%), lipids( 6.00%;6.00%), and fiber (8.70%; 6.45%) for the Tris buffer and warm aqueous extracts, respectively. The Tris and warm aqueous protein extracts showed antimicrobial effects toward all the human bacterial pathogens and two fungal isolates. CONCLUSIONS: This study revealed the potential ability of A. auricula-judae for use as a herbal antimicrobial in the treatment of human bacterial and fungal pathogens. Irrespective of the discovery and wonders of antimicrobial drugs, microbial infection is still a leading cause of morbidity and mortality worldwide. The menace has been aggravated by the unavailability of new antimicrobials and the persistent emergence and re-emergence of resistant microbial strains in the last few decades. Despite the impact and benefits of antimicrobial chemotherapy in modern medicine, microbial resistance is now a global threat [1] . Today, uncritical use of antibiotics has been the leading cause in the development of drugresistant bacteria. In addition, the consequence of acquired mutation assisting bacterial survival has also contributed to the non-susceptibility of microorganisms to commonly used antimicrobials [1] . This has increased the prevalence and incidence of opportunistic infections significantly beyond hospitalized patients, to the general population. The complexity in treating multi-drug resistant infections has led to an increase in the search for novel and effective antimicrobials, especially structures originating from natural products [2] . Research into natural products has demonstrated significant progress in the discovery of new compounds with antimicrobial activity because nature has generously handed us a source of compounds from medicinal plants, marine and terrestrial organisms, including fungi and bacteria which all has the potential to treat diseases, including infectious diseases [2] . Today, the need for novel antimicrobials has become greater than ever in the face of increasing resistance to the older ones, which has led to the exploitation of mushroom as an alternative source of protein both as food and antimicrobials [3, 4, 5] . Mushrooms are non-photosynthetic macrofungi with a fleshy distinctive fruiting body which can be either epigenous or hypogenous and visible to the naked eye [6, 7] . The biological value of mushrooms, as a food product containing a unique complex of biologically active substances, has been proved in recent decades [8, 9] . Edible fungi grown J o u r n a l P r e -p r o o f on plant residues contain proteins, all essential amino acids, unsaturated fatty acids, vitamins, macro and micro elements, polysaccharides, and melanin [10] . Mushrooms are superior nutritional supplements with excellent medicinal values and have been evaluated for their nutritional status and medicinal values based on their chemical composition [3, 8, 11] . Outside the nutritional and medicinal properties of edible mushrooms, they've also been reported to have antimicrobial activities [12, 13] . Like other bioactive compounds found in mushrooms, the proteins developed by these fungi have shown several biological activities including immunomodulatory effects, antiviral, antifungal, and antibacterial properties [3, 6, 8, 12, 14] . To date, one of the edible fungi that its biological properties have been proven is Auricularia auricular-judae. The A. auricular-judae, a specie that is well known as wood ear, tree ear, or black fungus originated from China where it grows mainly in decayed trees in the mountainside and more than 98% of the overall production of this mushroom is done in the aforementioned country [15, 16] . The fruiting bodies of members of the genus Auricularia are waxy and cartilaginous, and the color ranges from purplish-brown to black, especially when they are dried. The fruiting bodies are not only shaped like a human ear but also feel like ears, due to their rubbery, gelatinous state when fresh [10, 14, 17] . According to the previous studies [13, 18] that have shown antimicrobial effects of protein extract of some fungal species, this study hypothesized that the protein content of A. auriculajudae has a potential source of alternative treatment for microbial pathogens, but its therapeutic potential against microorganisms has not been evaluated till now. Hence this study aimed to evaluate the potential activities of the protein content of the aforementioned mushroom against some Gram-positive and Gram-negative bacteria, Dermatophytes and Candida albicans fungus. J o u r n a l P r e -p r o o f 7.3 and stirred for 3-4h. The homogenate was passed through a sieve cloth and centrifuged at 4500 rpm, for 30 minutes. The supernatants were saturated by adding cold acetone (80% v/v) and left overnight in the fridge (4°C). The collection of protein yield was done by centrifugation at 4000×g for 20min. This extract stored in the freezer at -20 °C until it needs. A 500 g of air-dried A. auricular-judae powder was poured into a beaker containing boiled warm water (50 °C) so that all the powder was immersed in water. The beaker was placed on a hot plate at 70 °C and allowed to stand for 4 hours with intermittent stirring. After 4 hours, the sample was filtered using sieve cloth. The homogenate was passed through a sieve cloth and centrifuged at 4500 rpm, for 30 minutes. The supernatants were saturated by adding cold acetone (80% v/v) and left overnight in the fridge (4 °C) [7] . The protein precipitate was collected by centrifugation at 4000×g for 20min and stored in the freezer at -20 °C until it was needed. The Tris buffer and warm aqueous extracts were subjected to qualitative and quantitative preliminary phytochemical screening to determine the bioactive compounds present in the mushroom using the following described methods [7, 26, 27] . Qualitative analysis was performed by adding of few drops of Mayer's reagent to solution comprised of a 0.5 g of extracts in 5 ml HCL (1%). The pale precipitate indicated the presence of alkaloids. For the quantitative evaluation of alkaloid, 200 ml of 10% acetic acid in ethanol was mixed with 2.5 g of extract, and stored at 27 °C for 4 h. After heating on a water bath, NH4OH was added until precipitation was finalized. After the settlement of the yield for 3 h J o u r n a l P r e -p r o o f and washing with 20 ml of 0.1 M NH4OH, the precipitate was recovered by decanting using Gem filter paper (12.5 cm) [7] . The filtrate was oven-dried until a constant weight was achieved. The alkaloid content was calculated as: % Alkaloid = (Initial Wt of Gem filter paper -Final Wt) 100 / Wt of Crude extract used The qualitative assay was done by adding a 0.1 g of the extract to 2 ml of distilled water. The addition of a few drops of sodium hydroxide generated an intense yellow color which became colorless on the addition of a few drops of dilute acid; suggesting the presence of flavonoids. For quantitative determination, 2.50 g of the extract was mixed with 50 ml of 80% aqueous methanol and stored at 25-27°C overnight. The sediment was recovered by decanting and reextraction carried out using 50 ml ethanol. The whole solution of ethanol extract was filtered with the Whatman paper number 42 (125 mm). The filtrate was evaporated to dryness until a constant weight was gained [7] . The flavonoids content was calculated as: % Flavonoid = (Initial Wt of Crucible -Final Wt of Crucible) 100 / Wt of Crude extract used The qualitative and quantitative protocols were performed exactly according to the references mentioned [7, 26, 27] . The value of each ingredient was calculated based on quantitative estimation per 100g of the dry weight of the sample. All bacterial test isolates were cultured on MHB and incubated at 37 °C for 18-24 hours, while fungal isolates were grown in MEB at 30°C for 48-72 hours. Then the turbidity of the suspensions was adjusted to 1.0 × 10 6 CFU/mL for agar well diffusion assay and micro-broth dilution [28] . The DIZ was determined by agar well diffusion. The MHA and MEA plate surfaces were inoculated by spreading a 100 µl volume of the microbial inoculum (1.0 × 10 6 CFU/mL) over the agar surface. Then, an 8mm hole punched aseptically with a sterile cork borer, and a volume of 30µl of the extract solutions was poured into the wells. The ciprofloxacin (5µg/mL) and fluconazole (12µg/mL) were used as a control for comparison of the results. The agar plates were incubated at 37 °C or 30 °C for 24 or 72 h depending on the test microorganism. The clear zone around the wells was measured and recorded in mm post-incubation and considered as the DIZ. This assay was done in triplicate and the results were shown as the mean value with the parallel standard deviation (SD) (28). The MIC of the protein extracts was determined using micro-broth dilution in sterile 96-well microplates. A 100 µl of protein extract with concentrations of 5 µg/mL, 2.5 µg/mL, 1.25 µg/mL, and 0.62 µg/mL, were poured in the wells 1, 2, 3, and 4 of each column, respectively. hours while those with fungi were incubated at 30°C for 72h. The MIC was determined as the lowest concentration which showed no visible growth. The procedure was repeated in triplicates to confirm the antimicrobial effects. The time-kill kinetics assay was performed according to the previously described method with slight modification [28] . Various values of the protein extracts were adjusted equal to MIC, 2 × MIC, and 4 × MIC. An inoculum of 1.0 × 10 6 CFU/ml was added and incubated at 37°C. A value of 1.0 mL of the sample were taken at time intervals of 0, 1, 2, 3, 4, 5, 6, 12 and cultured aseptically into 20 mL nutrient agar and incubated at 37°C for 24 hrs. Finally, the CFU of the pathogens was calculated and a graph of the log CFU/ml against time was made. In this study, the preliminary phytochemical analysis of the extracts revealed the presence of carbohydrate (43.15%; 38.30%), proteins (23.75%; 23.75%), flavonoids (1.20%; 0.80%), alkaloids (0.60%; 1.00%), saponin (6.00%; 2.40% ), tannin (1.65%; 1.57%), cyanide (0.24%; 0.40%), ash (12.40%; 10.40%), moisture (6.00%;6.00%), lipids( 6.00%;6.00%), and fiber (8.70%; 6.45%) for the Tris buffer and warm aqueous extracts, respectively ( Table 1 ). The J o u r n a l P r e -p r o o f amount of extracted compounds using Tris buffer did not differ significantly (p-value > 0.05) from that obtained from warm water. The results of agar well diffusion are presented in Table 2 . Both protein extracts showed antimicrobial effects against studied pathogens except for T. mentagrophytes, M. gypseum, and M. ferugineum. The Tris buffer protein extract showed the strongest effect against E. coli with DIZ of 6.00 ± 0.00 mm, followed by P. aeruginosa (4.00 ± 0.00 mm), and S. aureus (3.66 ± 0.53mm). The warm aqueous extract exhibited the most effectiveness against E. coli and S. aureus with the DIZ of 3.66 ± 0.53mm. Although ciprofloxacin and fluconazole antibiotics developed a larger inhibition zone diameter against studied pathogens than protein extracts, this difference was not significant (p-value > 0.05). The MIC of protein extracts was equal to 5 µg/mL for all pathogens except for E. coli (2.5 µg/mL) ( Table 3 ). In addition, the inhibitory effects of both Tris buffer and warm aqueous extracts were similar. Also, the two mushroom extracts had no activity against T. mentagrophytes, M. gypseum, and M. ferugineum. Among the test pathogens, the E. coli was the most sensitive microorganism to Tris and warm aqueous extracts. The killing rate kinetics of the Tris buffer compared with that of water protein extract (at 2× MIC) against test isolates are shown in Figures 1 and 2 The development of resistance to commonly used antibiotics amongst human pathogens is partly due to the misuse of these antimicrobial agents, which has led humans to seek new and alternative therapies. In this study, the phytochemical properties and anti-microbial effects of Tris buffer and warm water protein extracts of dry A. auricula-judea mushroom were J o u r n a l P r e -p r o o f evaluated. The phytochemical analysis of crude extracts revealed the presence of carbohydrate (43.15%; 38.30%), proteins (23.75%; 23.75%), flavonoids (1.20%; 0.80%), alkaloids (0.60%; 1.00%), saponin (6.00%; 2.40% ), tannin ( 1.65%; 1.57%), cyanide ( 0.24%; 0.40%), ash (12.40%; 10.40%), moisture (6.00%;6.00%), lipids ( 6.00%;6.00%), and fiber (8.70%; 6.45%), which was in line with the works of Essien et al. [29] , Khan et al. [30] , and Deka et al. [31] . Although the amount of protein extracted by the two solvents did not differ in this study, previous reports have shown that the type of solvent used in the extraction, temperature, pH, duration of extraction, and the presence of interfering materials can affect the extraction process [32, 33] . The results of this study revealed variable antimicrobial effects of the protein extracts on the selected organisms confirming the works of Tehrani et al. [13] , and Kavitha et al. [34] which recorded that Tris buffer and ultrasonic-assisted protein extracts of Agaricus mushroom were active against S. aureus, B. substilli, P. aeruginosa, K. pneumonia, and E. coli. However, in the work of Zheng et al. [35] , the mushroom protein extracts were not active against Pseudomonas batatae, Erwinia herbicola, E. coli, and S. aureus. In another study by Afzal et al. [36] , the antimicrobial ability of protein extracts from six medicinal plants Appiah et al. [28] , who reported that methanol extracts of Trametes elegans, Trametes gibbosa, Volvariella volvacea, and Schizophyllum commune mushrooms did not affect Aspergillus niger, Aspergillus flavus, and Aspergillus tamarii. It appears that the J o u r n a l P r e -p r o o f antibacterial properties of mushrooms are stronger than their antifungal properties. The Tris buffer and warm water protein extracts of A. auricula-judea indicated activity against all the bacteria isolates, C. albicans, and T. schoenleinii with a MIC of 5 µg/mL except for E. coli, whose, MIC was 2.5 µg/mL. There was no significant difference between the effects of the extracts on Gram-negative and Gram-positive bacteria, while previous studies reported that mushroom extracts have more antimicrobial activity against Gram-positive bacteria in comparison to Gram-negative bacteria [37] . It seems that some fungi have genes that can secrete peptides and proteins with antibiotic-like properties that can eradicate the both Grampositive and Gram-negative bacteria [18] . In the current research, the diameter of inhibition zone of studied protein extracts against the tested pathogens was lower than the ciprofloxacin and fluconazole antibiotics, while in a study by Al Akeel et al. [38] , the results have revealed a very robust effect of A. ascolinicum medicinal plant against E. coli and Proteus vulgaris with an inhibition zone of 17 mm, which was more than the control antibiotic chloramphenicol (25 µg) with a zone of inhibition equal to 8 mm. So far, few studies have examined the time-kill kinetics of mushrooms against microorganisms. In this study, the time-kill kinetic assay revealed that Tris buffer and warm water protein extracts of A. auricula-judea had bacteriostatic properties that were contrary to findings of Tinrat [39] who reported bactericidal activity of some mushrooms in his study. In line with the finding of the present research, Appiah et al. [28] , showed that methanol extracts of T. elegans, S. commune, V. volvacea, and T. gibbosa mushrooms had bacteriostatic action against E. coli ATCC 25922, S. aureus ATCC 25923, and C. albicans ATCC 25923. Besides, this study showed that both Tris buffer and warm water protein extracts had similar killing J o u r n a l P r e -p r o o f kinetics which approved that irrespective of the extraction solvent, the killing rate is dependent on the duration of exposure and concentration. In this study, due to the traffic restrictions because of the Coronavirus disease COVID-19related pandemic, we were unable to perform work on more samples and the study was completed in less than the allotted time. Due to the lack of enough financial sources the protein fractions extracted from mushroom were not analyzed and determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and chromatography. Besides, the mechanisms of action of A. auricula-judea against the test pathogens were not investigated. Further work should address these issues. This study documented that Tris and warm aqueous protein extracts of A. auricula-judae had antimicrobial effects against all the human bacterial pathogens and two fungal isolates; and therefore can be concluded that A. auricula-judae protein may have a potential antimicrobial fraction that can be used as an antimicrobial protein/peptides (AMP) in the treatment of human bacterial and fungal infections. The results showed that although the extracts are active against these organisms, they require enough time to exhibit their inhibition properties on the organisms. Before this study, A. auricula-judae, an edible tender mushroom that has quite a significant amount of protein has only been studied on a whole extract basis. The activities of the mushrooms bioactive substances have been published by several authors but nothing has been done on the proteins of this therapeutic and nutritional mushroom to evaluate its antimicrobial properties against some important human pathogens. With the results presented in this research, the alternate hypothesis is accepted that A. auricular-judae proteins have Determining the active fractions of these proteins and their antimicrobial effect in the in vivo studies or in combination with other chemicals or Manuscript drafting, editing, and final revising All authors read and approved the final manuscript Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections Antimicrobial compounds from natural sources Edible mushrooms: improving human health and promoting quality life Potentiality of oyster mushroom (Pleurotus spp.) in medicine-a review Antimicrobials from mushrooms for assuring food safety Phytochemical screening, total phenolic content, antibacterial and antioxidant activity of wild edible mushroom Pleurotus ostreatus Pleurotus ostreatus extract enhances the phagocytic actions of neutrophils against Streptococcus pneumonia Bioactivities and health benefits of mushrooms mainly from China Chemical composition and biological activities of methanol extract from Macrocybe lobayensis A review of the polysaccharide, protein and selected nutrient content of Auricularia, and their potential pharmacological value Survey and proximate analysis of edible mushrooms in Enugu State Antimicrobial activity and bioactive compounds of Indian wild Mushrooms, Indian Search for proteins in the liquid extract of edible mushroom, Agaricus bisporus, and studying their antibacterial effects Mushrooms: cultivation, nutritional value, medicinal effect, and environmental impact Comparative transcriptome analysis reveals the relationship of three major domesticated varieties of Auricularia auricula-judae Development of a molecular marker for fruiting body pattern in Auricularia auricula-judae Chemical and rheological properties of polysaccharides from fruit body of Auricularia auricular-judae Induction of antibacterial proteins and peptides in the coprophilous mushroom Coprinopsis cinerea in response to bacteria Molecular investigation of Staphylococcus aureus, coa and spa genes in Ahvaz hospitals' staff nose compared with patients clinical samples Preliminary survey of extended-spectrum β-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran Prevalence and antimicrobial resistance of Shigella species isolated from diarrheal patients in Ahvaz, southwest Iran Characterization of metallo-β-lactamases-encoding genes blaIMP-1 and blaVIM-1 amongst Klebsiella pneumoniae from abattoir samples of Ebonyi state, southeastern Nigeria Prevalence of enterotoxin-encoding genes among diverse Shigella strains isolated from patients with diarrhea, southwest Iran Isolation and identification of Candida species in patients with orogastric cancer: susceptibility to antifungal drugs, attributes of virulence in vitro and immune response phenotype El-Hamd, Isolation, identification, and in vitro antifungal susceptibility testing of dermatophytes from clinical samples at Sohag University Hospital in Egypt Textbook of Pharmacognosy Phytochemical Methods-A Guide to Modern Techniques of Plant Analysis Antimicrobial activities and time-kill kinetics of extracts of selected Ghanaian mushrooms Proximate composition and anti-nutritive factors in some wild edible medicinal macrofungi Nutritional and chemical profiles of Auricularia auricular mushrooms: A review Antimicrobial properties and phytochemical screening of some wild macrofungi of Rani-Garbhanga reserve forest area of Assam Phytochemicals: extraction, isolation, and identification of bioactive compounds from plant extracts Effect of ecofriendly bio-based solvents on oil extraction from green coffee bean and its industrial press cake Ultrasonic-assisted extraction and antibacterial activites of protein recovred from white button mushroom (Agaricusbisporus) Purification and characterization of an antibacterial protein from dried fruiting bodies of the wild mushroom Clitocybe sinopica Comparison of the antimicrobial activity of seed protein extracts from six medicinal plants against Staphylococcus aureus 6736152 The antibacterial activity of Coriolus versicolor methanol extract J o u r n a l P r e -p r o o f and its effect on ultrastructural changes of Staphylococcus aureus and Salmonella Enteritidis Evaluation of antibacterial activity of crude protein extracts from seeds of six different medical plants against standard bacterial strains, Saudi Antimicrobial activities and synergistic effects of the combination of some edible mushroom extracts with antibiotics against pathogenic strains Guarantor of integrity of the entire study and manuscript preparation: Angus Nnamdi Oli, Peter Anyigor Edeh, Nancy Amara Mbachu.Supplementary material related to this article can be obtained from the corresponding author on request.